The moderating role of coping flexibility in reports of somatic symptoms among early breast cancer patients.


Journal

Social science & medicine (1982)
ISSN: 1873-5347
Titre abrégé: Soc Sci Med
Pays: England
ID NLM: 8303205

Informations de publication

Date de publication:
09 2022
Historique:
received: 29 01 2022
revised: 30 06 2022
accepted: 11 07 2022
pubmed: 22 7 2022
medline: 18 8 2022
entrez: 21 7 2022
Statut: ppublish

Résumé

The current study assessed breast cancer patients' somatic symptoms during the first six months post diagnosis and examined the moderating role of coping flexibility (i.e., trauma-focused and forward-focused coping strategies) on the association between reported somatic symptoms three months after breast cancer diagnosis and somatic symptoms six months after diagnosis. An international sample of 702 women diagnosed with breast cancer from four countries (Finland, Israel, Italy, Portugal) completed self-reported questionnaires at three time points: at the time of diagnosis (M0), three months post diagnosis (M3), and six months post diagnosis (M6). The questionnaires included the coping flexibility scale and questions about demographics, medical data, and somatic symptoms. The highest level of somatic symptoms was reported after three months post diagnosis (M3), as compared to M0 and M6. Both trauma-focused and forward-focused coping strategies moderated the relationship between somatic symptoms at M3 and somatic symptoms at M6. The findings highlight the importance of assessing somatic symptoms soon after breast cancer diagnosis and throughout the early phase of treatment. Coping flexibility can buffer the stability of the somatic symptoms during this initial phase.

Identifiants

pubmed: 35863152
pii: S0277-9536(22)00525-1
doi: 10.1016/j.socscimed.2022.115219
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

115219

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Rawan Dahabre (R)

Paul Baerwald School of Social Work and Social Welfare, Hebrew University of Jerusalem, Israel.

Ilan Roziner (I)

Department of Communication Disorders, Tel-Aviv University, Tel-Aviv, Israel.

Gabriella Bentley (G)

Paul Baerwald School of Social Work and Social Welfare, Hebrew University of Jerusalem, Israel.

Paula Poikonen-Saksela (P)

Helsinki University Hospital Comprehensive Cancer Center, Helsinki University, Helsinki, Finland.

Ketti Mazzocco (K)

Department of Oncology and Hemato-oncology, University of Milan, Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, Milan, Italy.

Berta Sousa (B)

Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Champalimaud Research, Lisboa, Portugal.

Ruth Pat-Horenczyk (R)

Paul Baerwald School of Social Work and Social Welfare, Hebrew University of Jerusalem, Israel. Electronic address: ruth.pat-horenczyk@mail.huji.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH